Adults who sleep only three to five hours a day are at higher risk of developing type 2 diabetes. This is demonstrated in a new study from Uppsala University, published in JAMA Network Open.
Anti-CD19 Monoclonal Antibody Shows Positive Results in Myasthenia Gravis
SAVANNAH, Ga. — Inebilizumab (Uplizna) had clinically meaningful efficacy and a favorable safety profile among people with generalized myasthenia gravis (gMG), topline data from the
October 16, 2024